News
A new marker of good prognosis in metastatic uveal melanoma has been identified
IDIBELL-ICO researchers propose a new favourable prognostic marker in metastatic uveal melanoma that could serve to clarify the prognostic outlook of patients with metastasis.
The risk of developing diabetes is reduced with the combination of Mediterranean diet and physical activity
The combination of a low-calorie Mediterranean diet and physical activity can help prevent new cases of type II diabetes.
Brisk walking or dancing 20 minutes a day reduces the risk of starting treatment with psychotropic drugs in older people
Following a Mediterranean diet and exercising can help prevent psychotropic drug treatment in older adults.
A clinical trial with the participation of HUB and IDIBELL proposes alternatives to the treatment of resistant depression
Switching antidepressants or combining it with psychotherapy is more effective than increasing the dose in treatment-resistant patients with major depression.
Advances in precision oncology and hereditary cancer: researchers describe the clinical and molecular impact of mutations in key genes for DNA replication and repair
IDIBELL researchers have conducted an in-depth characterization of all known pathogenic variants in the POLE and POLD1 genes, which are essential for DNA repair and replication.
25 years of the Human Genome: AI and biological chemistry break in to help decode the secrets of the genome
A global initiative has been launched to help understand the genome with the help of AI and biological chemistry, and thus facilitate drug discovery.
Food addiction does not prevent the success of bariatric surgery, but it can increase the risk of weight regain
Food addiction is not a barrier to achieving significant weight loss, but it can increase the risk of regaining weight over the years.
Bioinformatics team drives significant improvements in hereditary cancer prevention and treatment
A bioinformatics team devises a reliable and open access guide to choosing the best bioinformatics tools for CNV detection.
Bellvitge participates in research that studies the lineages of pneumococcal serotype 8, the bacterium responsible for pneumococcal disease and pneumonia
Pneumococcal serotype 8 has become one of the main causes of invasive pneumococcal disease in Spain, both in adults and in the pediatric population.